🇩🇪 Germany Country × Condition
multiple sclerosis Clinical Trials in Germany
Active clinical trials for multiple sclerosis with research sites in Germany. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 3 // Recruiting: 3 Phases: Phase 1 // Updated: Daily
Total Trials
3
Recruiting Now
3
Country
🇩🇪 Germany
Active Trials in Germany (3)
NCT05170126
Recruiting
A Study on the Safety of Ozanimod Exposure in Pregnant Women and Their Offspring
Enrollment
1,182 pts
Country
🇩🇪 Germany
Bristol-Myers Squibb
View Trial → NCT05704361 Phase 1
Recruiting
A Study to Investigate the Safety, Tolerability, and Processing by the Body of Intravenous and Subcutaneous RO7121932 Administration in Participants With Multiple Sclerosis
Enrollment
119 pts
Country
🇩🇪 Germany
Hoffmann-La Roche
View Trial → NCT06280755
Recruiting
Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study.
Enrollment
7,000 pts
Country
🇩🇪 Germany
icometrix
View Trial → Frequently Asked Questions
How many multiple sclerosis clinical trials are active in Germany?
There are currently 3 active clinical trials for multiple sclerosis with sites in Germany, of which 3 are actively recruiting patients.
How can I join a multiple sclerosis clinical trial in Germany?
To join a multiple sclerosis clinical trial in Germany, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Germany directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are multiple sclerosis trials in Germany?
Active multiple sclerosis trials in Germany span Phase 1. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology